2008
DOI: 10.1016/j.nut.2008.05.004
|View full text |Cite
|
Sign up to set email alerts
|

Tolerability and safety of olive oil–based lipid emulsion in critically ill neonates: A blinded randomized trial

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
39
0
3

Year Published

2010
2010
2019
2019

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 55 publications
(44 citation statements)
references
References 39 publications
2
39
0
3
Order By: Relevance
“…An RCT in critically ill neonates requiring parenteral nutrition in the first week of life reported similar results in terms of fatty acid levels and oxidative stress (F 2 -isoprostanes) [23]. Roggero et al [24 ] conducted a threearm RCT in preterm neonates (gestation 28-33 weeks) randomized to receive either soybean oil-based lipid emulsion (Intralipid, B. Braun), or olive oil-based lipid emulsion (Clinoleic, Baxter Pharmaceuticals), or soybean oil/MCT-based lipid emulsion (Lipofundin, B. Braun).…”
Section: Oxidative Stress and Fatty Acid Levelsmentioning
confidence: 78%
“…An RCT in critically ill neonates requiring parenteral nutrition in the first week of life reported similar results in terms of fatty acid levels and oxidative stress (F 2 -isoprostanes) [23]. Roggero et al [24 ] conducted a threearm RCT in preterm neonates (gestation 28-33 weeks) randomized to receive either soybean oil-based lipid emulsion (Intralipid, B. Braun), or olive oil-based lipid emulsion (Clinoleic, Baxter Pharmaceuticals), or soybean oil/MCT-based lipid emulsion (Lipofundin, B. Braun).…”
Section: Oxidative Stress and Fatty Acid Levelsmentioning
confidence: 78%
“…Olive oil based lipid emulsions have been found to be well tolerated by critically ill and preterm neonates. [3,4,5,6]. Several in vitro and animal studies have reported suppression of T-lymphocyte function and impaired bacterial clearance by soybean oil based lipid emulsion compared with minimal effect from olive oil based emulsion.…”
Section: Spn Formulationsmentioning
confidence: 99%
“…In addition there are concerns regarding excess of poly-unsaturated fatty acids (PUFAs) and low vitamin E levels in soybean oil based lipid emulsions [8]. Although, the clinical studies have failed to show any short term benefits of using olive oil based emulsions on fatty acid profile and anti-oxidant properties, the fatty acid profile of preterm neonates in Clinoleic group was similar to breast milk fed preterm neonates [4,5,6]. ClinOleic ® 20% lipid emulsion contains a mixture of 80% olive oil and 20% soybean oil and is given as a 24 h infusion piggy-backed to the rest of the PN solution containing glucose, amino acids, electrolytes and vitamins.…”
Section: Spn Formulationsmentioning
confidence: 99%
“…In one small randomized clinical trial comparing soybean oil-and olive oil-based emulsions, olive oil emulsions were found to be well-tolerated in ELBW infants, resulting in comparable measures of peroxidation to those seen with soybean oil-based lipid emulsions [18]. Similar results were observed in a randomized, double-blind comparison of olive oil emulsion with soybean oil emulsion in critically ill neonates [19]. Gobel et al [20] compared their standard soybean lipid emulsion to one in which olive oil and soybean oil were combined (4 : 1) and in which additional ␣tocopherol was provided.…”
Section: Recent Developments In Tpn For Lbw Neonatesmentioning
confidence: 65%